Clinical Trial Update: Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial update on tilmanocept tracing and dynamics in early stage breast cancer, withdrew the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Sentinel Lymph Node

Drugs mentioned

• Tilmanocept (Tilmanocept)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Breast Cancer, Sentinel Lymph Node | Phase 4 | Status: WITHDRAWN